Semaglutide & weight loss
Introduction An obesity drug remains one of the biggest opportunities for pharmaceutical companies, but it has proved to be one
Read moreIntroduction An obesity drug remains one of the biggest opportunities for pharmaceutical companies, but it has proved to be one
Read moreIntroduction Last week, I received a really interesting email from a long-term supporter. ‘Debbie’ is due to have a knee
Read moreWe’ve been dissecting the Seven Countries Study for the past couple of weeks – putting to bed the myth that
Read moreThis is a copy of an email, which I have just sent to the UK National Institute for Care and
Read moreThere were two interesting statin stories this week. On Friday March 17th 2017, the front page of the UK Express
Read moreOn Friday 9th September 2016, an article was published in The Lancet with a quite extraordinary editorial. The full article
Read moreDr Jeffry N Gerber – Cholesterol OMG! To view full screen, just click the little icon at the bottom right
Read moreThe shock story of last week broke on 11th May. The UK GP magazine, Pulse, reported that The Medicines and
Read moreIntroduction In May 2014, two doctors were maliciously attacked by a researcher. The researcher heads up the Clinical Trial Service
Read moreIf I told you that a drug went on sale on 1st September 2015, which involved fortnightly injections at a
Read more